Participated · Seed · Mar 2026

NextWork offers an online platform where learners build real AI projects—such as chatbots and automated workflows—and publish authenticated portfolios that employers can easily verify. By shifting focus from traditional credentials to demonstrable outcomes, the company serves as a trust layer for AI-related hiring. Since its 2024 launch, more than 190,000 users in over 190 countries have completed projects on the site, with 22% of those projects created by U.S. learners aged 25–35. The company plans to establish its U.S. headquarters in Austin, Texas and will direct new funds toward engineering and growth hiring. NextWork’s model addresses the widening AI skills gap, helping individuals switch careers or earn promotions by showcasing concrete abilities. Financial details beyond user metrics have not been publicly disclosed, but recent backing underscores investor confidence in its growth trajectory.

Participated · Series A · Dec 2024

Culina Health, founded in 2020 by dietitians Vanessa Rissetto and Tamar Samuels, provides virtual access to registered dietitians for chronic disease prevention, wellness, and weight-loss counseling using its Culina Health Method. The company emphasizes culturally-affirming, nonjudgmental care and increasing diversity among nutrition providers. Culina already works with insurance companies and Medicare and says at least 70% of the U.S. can access its platform. The startup has served more than 10,000 patients to date. With the new funding it plans to expand and enhance its nutrition counseling, implement AI platforms to improve care efficiency and reduce clinician burden, and strengthen its leadership team with key hires. The company positions itself as offering personalized, clinically rigorous nutrition care rather than one-size-fits-all solutions. Culina Health operates a personalized nutrition platform that delivers clinical-level care exclusively through registered dietitians. The company has grown for 18 months via bootstrapping to a 20-practitioner practice and has delivered over 18,000 sessions to date. Culina is covered by most major insurance plans and works alongside existing care providers and insurers to make nutrition more affordable and accessible. The platform positions registered dietitians at the center of preventive and chronic-care nutrition, targeting broad demand for clinical nutrition services. Culina is based in Hoboken, NJ and serves patients across the United States. Funds from the announced round will support continued product development, technology investment, and geographic and service expansion.

Led · Equity · Feb 2024

Aster offers a vertically integrated platform that combines patient-facing features (asynchronous messaging, telehealth, remote patient monitoring, and educational resources) with provider-focused clinical administration and remote-monitoring tools. The patient app—full release planned for Q2 2024—enables Bluetooth-enabled tracking of blood pressure, heart rate, blood glucose, and urinalysis, plus direct communication with care teams. For providers, Aster’s software streamlines scheduling, charting, intake, and supports telehealth and network consolidation to expand practice capacity. The company launched in June 2023, initially focusing on midwifery-led care, birth centers, and nurse practitioner–led care, with plans to serve OB/GYN providers soon after. Aster has 30 clinics signed up from a private pilot and is onboarding providers and patients across several U.S. states, including California and Texas; it expects to work with more than 100 providers and serve approximately 20,000 patients by year end. The founding team includes Fifi Kara, Dr. Lailah Kara-Newton, and Andrew Q. Tran, and the core staff comprises physicians, engineers, policy advisors, and product leaders. The company raised its first institutional funding to accelerate scaling, nationwide availability, and hiring of key operational roles.

Participated · Seed · Apr 2023

Eli builds a palm-sized at-home testing system that measures minuscule amounts of hormones in saliva to provide daily hormonal data. The product targets unmet needs across menopause, fertility, contraception, and endocrine conditions by enabling continuous, timely hormone monitoring. Eli’s scientific and engineering breakthroughs stem from years of R&D to make continuous saliva monitoring accurate and affordable for long-term home use. The company says users collect a tiny saliva sample, insert it into the reader, and receive results in minutes via an app. The new funding will let Eli finalize product development and advance through clinical validation and regulatory approvals toward commercial launch. Since launching in 2019, Eli has raised a total of CAD $9 million, including a CAD $1.9 million pre-seed in 2020. Eli develops a saliva-based at-home device and companion app that capture hormone fluctuations and provide daily, personalized information based on each user’s evolving hormonal profile. The company positions its product to help women own their fertility and broader health decisions. Led by CEO and co-founder Marina Pavlovic Rivas, Eli combines hardware and software with clinical and academic partnerships. The company plans to use new capital for product development, clinical validations with independent medical centers, and initial strategic sales. Eli will continue collaborating with academic institutions to advance women’s health research. Financially, the company raised a seed round that increases its total funding since creation in mid-2019.

Participated · Seed · Nov 2022

Guaranteed provides tech-enabled hospice services through a hybrid home model with 24/7 telemedicine coverage and well-trained in-person care. The company designs end-of-life care with patients and caregivers in mind and emphasizes inclusivity across races, abilities, genders, sexualities, and religions. Guaranteed will use its $6.5M seed to scale its platform, build out the patient experience, and expand into new markets. Hiring plans include hospice and clinical care professionals as well as engineering and marketing talent. The team combines expertise across healthcare, tech, and public policy to improve the hospice experience. The company positions itself to change how dying and death are treated in the U.S.